Cargando…
AT2R agonist NP‐6A4 mitigates aortic stiffness and proteolytic activity in mouse model of aneurysm
Clinical and experimental studies show that angiotensin II (AngII) promotes vascular pathology via activation of AngII type 1 receptors (AT1Rs). We recently reported that NP‐6A4, a selective peptide agonist for AngII type 2 receptor (AT2R), exerts protective effects on human vascular cells subjected...
Autores principales: | Sharma, Neekun, Belenchia, Anthony M., Toedebusch, Ryan, Pulakat, Lakshmi, Hans, Chetan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339180/ https://www.ncbi.nlm.nih.gov/pubmed/32420690 http://dx.doi.org/10.1111/jcmm.15342 |
Ejemplares similares
-
Cell-Specific Protective Signaling Induced by the Novel AT2R-Agonist NP-6A4 on Human Endothelial and Smooth Muscle Cells
por: Toedebusch, Ryan, et al.
Publicado: (2018) -
Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures
por: Toedebusch, Ryan, et al.
Publicado: (2018) -
Interleukin 12p40 Deficiency Promotes Abdominal Aortic Aneurysm by Activating CCN2/MMP2 Pathways
por: Sharma, Neekun, et al.
Publicado: (2021) -
Suppression of Inflammatory Cardiac Cytokine Network in Rats with Untreated Obesity and Pre-Diabetes by AT2 Receptor Agonist NP-6A4
por: Gavini, Madhavi P., et al.
Publicado: (2021) -
Comparison of Cardiac miRNA Transcriptomes Induced by Diabetes and Rapamycin Treatment and Identification of a Rapamycin-Associated Cardiac MicroRNA Signature
por: Belenchia, Anthony M., et al.
Publicado: (2018)